医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: The COSMOS randomised study

广告
第一作者: Lawitz,E.
作者单位: Atlanta Medical CenterAtlanta, GA, United States [1] Yale Liver Center and Yale University School of MedicineNew Haven, CT, United States [2] Texas Clinical Research InstituteArlington, TX, United States [3] Orlando Immunology CenterOrlando, FL, United States [4] Borland-Groover ClinicJacksonville, FL, United States [5] Gilead Sciences IncFoster City, CA, United States [6] University of Pittsburgh Medical CenterPittsburgh, PA, United States [7] Atlanta Gastroenterology AssociationAtlanta, GA, United States [8] Harborview Medical CenterSeattle, WA, United States [9] Janssen Research and DevelopmentBeerse, Belgium [10] Department of Medicine, Inova Fairfax HospitalFalls Church, VA, United States [11] Janssen Research and DevelopmentTitusville, NJ, United States [12] Texas Liver Institute, University of Texas Health Science Center, 607 Camden StreetSan Antonio, TX [13] Novellas HealthcareZellik, Belgium [14] Johns Hopkins University School of MedicineBaltimore, MD, United States [15] Fundación de InvestigaciónSan Juan, PR, United States [16] Weill Cornell Medical CollegeNew York, NY, United States [17] Scripps ClinicSan Daigo, CA, United States [18]
发布时间 2015-03-02
提交
  • 浏览2
The Lancet

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷